Sec Form 13D Filing - Koito Manufacturing Co. Ltd. filing for CEPTON INC WT EXP (CPTNW) - 2022-09-08

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549
 

SCHEDULE 13D/A

 

Under the Securities Exchange Act of 1934

(Amendment No. 2)

 
CEPTON, INC.
(Name of Issuer)
 
Common Stock, par value $0.00001 per share
(Title of Class of Securities)
 
15673X 101
(CUSIP Number)
 

Satoshi Kabashima

KOITO MANUFACTURING CO., LTD.

4-8-3, Takanawa, Minato-ku

Tokyo 108-8711

Japan

Telephone: +81-3-3447-5142

(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
 
September 6, 2022
(Date of Event which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-l(f) or 240.13d-l(g), check the following box.  
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

Page 1 of 3 Pages

CUSIP No. 15673X 101
1. Names of Reporting Persons.
KOITO MANUFACTURING CO., LTD.
2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

(b)

3.

SEC Use Only

 

4.

Source of Funds (See Instructions)

WC

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)      ☐

 

6.

Citizenship or Place of Organization

Japan

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING

PERSON WITH

7.

Sole Voting Power

19,624,741 shares of Common Stock

8.

Shared Voting Power

0

9.

Sole Dispositive Power

19,624,741 shares of Common Stock

10.

Shared Dispositive Power

0

11.

Aggregate Amount Beneficially Owned by Each Reporting Person

19,624,741 shares of Common Stock

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

13.

Percent of Class Represented by Amount in Row (11)

12.6%*

14.

Type of Reporting Person (See Instructions)

CO

 

* Based on 155,608,919 shares of Common Stock outstanding as of August 1, 2022, as reported in the Cepton, Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022 filed with the Securities and Exchange Commission on August 11, 2022.

 

 

Page 2 of 3 Pages

 

Item 1. Security and Issuer

 

This statement constitutes Amendment Number 2 to the Schedule 13D (this “Statement”) relating to shares of common stock, par value $0.00001 per share (“Common Stock”), of Cepton, Inc., a Delaware corporation, whose principal executive offices are located at 399 West Trimble Road, San Jose, California 95131, and its designated business telephone number is (408) 459-7579 (the “Issuer”), and hereby amends the Schedule 13D filed with the Securities and Exchange Commission on February 18, 2022 (as amended from time to time, the “Initial Statement”) on behalf of the Reporting Person to furnish the additional information set forth herein. Information given in response to each item shall be deemed incorporated by reference in all other items as applicable.

 

Item 4. Purpose of Transaction

 

Item 4 is hereby supplemented by adding the following paragraphs:

 

On September 6, 2022, the Issuer entered into an exclusivity agreement (the “Exclusivity Agreement”) with the Reporting Person which grants the Reporting Person a 30-day exclusivity period during which the Issuer agreed not to, directly or indirectly, solicit, participate in negotiations with or furnish any confidential information to any person other than the Reporting Person with respect to the Issuer or any of its subsidiaries in connection with, or approve or enter into any agreement relating to, any alternative third-party proposal to make a material investment in, acquire a material equity interest in, or acquire a material portion of the assets of, the Issuer. Under the terms of the exclusivity agreement, the Issuer is not prohibited from soliciting, negotiating with, furnishing confidential information to, or approving or entering into any agreements with banks, lenders (except for strategic business partners) and other financial institutions for debt financing transactions. At this time, there can be no assurances that the Issuer will or will not enter into any definite agreements with the Reporting Person, issue any securities to the Reporting Person (including the CPS) or otherwise enter into any other strategic corporate transactions with the Reporting Person or, following expiration of the exclusivity period, any other third party.

 

A copy of the Exclusivity Agreement is filed as Exhibit 99.2 to this Statement, and is incorporated by reference into this Item 4.

 

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer

 

Item 6 of the Initial Statement is hereby amended by incorporating by reference in its entirety the Exclusivity Agreement and the other matters set forth in Item 4 above.

 

Item 7. Material to be Filed as Exhibits

 

Exhibit No. 

  Description
     
99.2   Exclusivity Agreement, between the Reporting Person and the Issuer dated as of September 6, 2022 (filed herewith).

 

 

 

Page 3 of 3 Pages

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: September 8, 2022

 

  KOITO MANUFACTURING CO., LTD.
     
  By:  

/s/ Hideharu Konagaya

  Name:   Hideharu Konagaya
  Title:   Senior Managing Director